Depression and glycaemic control among adult patients with type 2 diabetes: a cross-sectional study in a comprehensive specialised hospital, Jigjiga, Ethiopia

• Published in: BMJ open 2023-11, Vol.13 (11), p.e073123-e073123
• Main Authors: Ali, Seid Yimam, Seid, Ahmed Muhye, Hassen, Kalkidan, Abebe, Samuel Taddese, Banjaw, Zelalem, Ibrahim, Mohammed
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Chronic illnesses; Cross-Sectional Studies; Data collection; Depression & mood disorders; Depression - epidemiology; Developing countries; Diabetes; DIABETES & ENDOCRINOLOGY; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - epidemiology; Disease; Ethiopia - epidemiology; Female; Glycemic Control; Hemoglobin; Hormones; Hospitals; Hospitals, Special; Humans; Hyperglycemia; LDCs; Male; Mental depression; Mental disorders; Mental health; NEUROLOGY; Patients; Questionnaires; Sample size; Sociodemographics
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-073123

ObjectivesThe primary objective of this study was to evaluate the prevalence of depression and its sociodemographic predictors, clinical predictors and glycaemic control among adult patients with type 2 diabetes at Sheik Hassan Yabare Comprehensive Specialized Hospital (SHYCSH), Jigjiga, Ethiopia.DesignA hospital-based cross-sectional study was conducted.SettingPatients with type 2 diabetes mellitus (T2DM) at Sheik Hassan Yabare Comprehensive Specialized Hospital, for chronic follow-up from 3 October 2022 to 13 November 2022.ParticipantsRandomly selected 278 patients with T2DM age 18 years and older, with a duration of 1 year or more since diagnosis, who had a diabetic follow-up at SHYCSH.Main outcome measuresDepression was assessed using the Patient Health Questionnaire.ResultsA total of 263 participants were included, with a response rate of 94.6%. Of the respondents, 134 (51%) were male, making up more than half of the total. The overall prevalence of depression was 47.1% (95% CI 41.1 to 53.2). Depression was further classified, as follows, based on its severity: the majority (66 or 25.1%) had mild depression, followed by 44 (16.7%) with moderate depression, 9 (3.4%) with moderately severe depression and 5 (1.9%) with severe depression. A multivariable logistic regression analysis indicated that poor glycaemic control (adjusted OR (AOR)=1.93; 95% CI 1.05 to 3.53), DM complications (AOR=2.02; 95% CI 1.09 to 3.74) and DM duration of 6–10 years since diagnosis (AOR=2.29; 95% CI 1.21 to 4.34) were independently associated with depression.ConclusionsOur study revealed a significant burden of depression among patients with T2DM receiving follow-up care at the hospital. Glycaemic control, the presence of complications and a longer duration of diabetes were identified as predictors of depression. Therefore, concerned stakeholders should work to improve blood sugar control and promote healthy behaviour, particularly among those with complications or who have been sick for an extended period of time.